litlas
ログインアカウント作成

Tadeusz Pieńkowski

1997–2024 年に発表

47
論文数
23,933
被引用数
43
h 指数
47
i10 指数

被引用数

Tadeusz Pieńkowski の年別被引用数1974 年: 被引用 1 件1998 年: 被引用 1 件1999 年: 被引用 6 件2000 年: 被引用 3 件2001 年: 被引用 1 件2002 年: 被引用 4 件2003 年: 被引用 12 件2004 年: 被引用 29 件2005 年: 被引用 43 件2006 年: 被引用 59 件2007 年: 被引用 110 件2008 年: 被引用 202 件2009 年: 被引用 178 件2010 年: 被引用 177 件2011 年: 被引用 142 件2012 年: 被引用 206 件2013 年: 被引用 276 件2014 年: 被引用 255 件2015 年: 被引用 237 件2016 年: 被引用 229 件2017 年: 被引用 245 件2018 年: 被引用 214 件2019 年: 被引用 617 件2020 年: 被引用 574 件2021 年: 被引用 588 件2022 年: 被引用 484 件2023 年: 被引用 348 件2024 年: 被引用 478 件2025 年: 被引用 220 件2026 年: 被引用 8 件1975〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,021 件、この内訳の 23.7%中国: 引用元論文 573 件、この内訳の 6.7%イタリア: 引用元論文 546 件、この内訳の 6.4%イギリス: 引用元論文 537 件、この内訳の 6.3%ドイツ: 引用元論文 446 件、この内訳の 5.2%スペイン: 引用元論文 364 件、この内訳の 4.3%フランス: 引用元論文 344 件、この内訳の 4%カナダ: 引用元論文 339 件、この内訳の 4%スイス: 引用元論文 318 件、この内訳の 3.7%ベルギー: 引用元論文 277 件、この内訳の 3.2%日本: 引用元論文 224 件、この内訳の 2.6%オーストラリア: 引用元論文 212 件、この内訳の 2.5%
0%23.7%その他 27.4%

機関

分野

  • Medicine67.2%
  • Biochemistry, Genetics and Molecular Biology27.1%
  • Immunology and Microbiology1.4%
  • Computer Science1.1%
  • Materials Science0.7%
  • Mathematics0.5%
  • その他2%

トピック

  • HER2/EGFR in Cancer Research14.4%
  • Breast Cancer Treatment Studies10.4%
  • Cancer Treatment and Pharmacology6%
  • Advanced Breast Cancer Therapies5.8%
  • Monoclonal and Polyclonal Antibodies Research4.7%
  • Chemotherapy-induced cardiotoxicity and mitigation2.5%
  • その他56.2%

共著者

全論文

検索で開く
  1. Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

    著者: Luca Gianni, Tadeusz Pieńkowski, Young‐Hyuck Im, Laslo Roman, Ling‐Ming Tseng, Mei-Ching Liu, Aňa Lluch, Elżbieta Starosławska, Juan de la Haba-Rodríguez, Seock‐Ah Im, José Luiz Pedrini, Brigitte Poirier, Paolo Morandi, Semiglazov Vf, Vichien Srimuninnimit, Giulia Bianchi, Tania Szado, Jayantha Ratnayake, Graham Ross, Pinuccia Valagussa - The Lancet Oncology 2011 被引用: 2,358

  2. Adjuvant Trastuzumab in HER2-Positive Breast Cancer

    著者: Dennis J. Slamon, W. Eiermann, Nicholas J. Robert, Tadeusz Pieńkowski, Miguel Martín, Michael F. Press, John R. Mackey, John A. Glaspy, Arlene Chan, Marek Pawlicki, Tamás Pintér, Vicente Valero, Mei-Ching Liu, Guido Sauter, Gϋnter von Minckwitz, F. Visco, Valerie Bée, Marc Buyse, Belguendouz Bendahmane, Isabelle Tabah-Fisch, Mary-Ann Lindsay, A. Riva, John Crown - New England Journal of Medicine 2011 被引用: 2,775

  3. Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

    著者: José Baselga, Javier Cortés, Sung‐Bae Kim, Seock‐Ah Im, Roberto Hegg, Young‐Hyuck Im, Laslo Roman, José Luiz Pedrini, Tadeusz Pieńkowski, Adam Knott, Emma Clark, Mark Benyunes, Graham Ross, Sandra M. Swain - New England Journal of Medicine 2011 被引用: 2,523

  4. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

    著者: Christina Davies, Hongchao Pan, Jon Godwin, Richard Gray, R. Arriagada, Vinod Raina, Mirta Abraham, Victor Hugo Medeiros Alencar, A. S. Badran, Xavier Bonfill, Joan Bradbury, Michael Clarke, Rory Collins, Susan R. Davis, Antonella Delmestri, John Forbes, Peiman Haddad, Ming‐Feng Hou, Moshe Inbar, Hussein Khaled, Joanna Kielanowska, Wing-Hong Kwan, Beela Sarah Mathew, Indraneel Mittra, Bettina Müller, Antonio Nicolucci, O Peralta, Fany Pernas, Luboš Petruželka, Tadeusz Pieńkowski, Ramachandran Radhika, Balakrishnan Rajan, Maryna T Rubach, Sera Tort, Gerard Urrútia, Miriam Valentini, Yaochen Wang, Richárd Pető - The Lancet 2012 被引用: 2,039

  5. 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial

    著者: Luca Gianni, Tadeusz Pieńkowski, Young‐Hyuck Im, Ling‐Ming Tseng, Mei-Ching Liu, Aňa Lluch, Elżbieta Starosławska, Juan de la Haba-Rodríguez, Seock‐Ah Im, José Luiz Pedrini, Brigitte Poirier, Paolo Morandi, Semiglazov Vf, Vichien Srimuninnimit, Giulia Bianchi, Domenico Magazzù, Virginia McNally, Hannah Douthwaite, Graham Ross, Pinuccia Valagussa - The Lancet Oncology 2016 被引用: 874

  6. Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

    著者: Charles E. Geyer, John Forster, Deborah Lindquist, Stephen Chan, C. Gilles Romieu, Tadeusz Pieńkowski, Agnieszka Jagiełło-Gruszfeld, John Crown, Arlene Chan, Bella Kaufman, Dimosthenis Skarlos, Mario Campone, Neville Davidson, Mark S. Berger, Cristina Oliva, Stephen D. Rubin, Steven Stein, David Cameron - New England Journal of Medicine 2006 被引用: 3,461

  7. Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up

    著者: Martine Piccart, Marion Procter, Debora Fumagalli, Evandro de Azambuja, Emma Clark, Michael S. Ewer, Eleonora Restuccia, Guy Jérusalem, Susan Dent, Linda Reaby, Hervé Bonnefoi, Ian E. Krop, Tsang‐Wu Liu, Tadeusz Pieńkowski, Masakazu Toi, Nicholas Wilcken, Michael Andersson, Young‐Hyuck Im, Ling‐Ming Tseng, Hans-Joachim Lueck, Marco Colleoni, Estefanía Monturus, Mihaela Sicoe, Sébastien Guillaume, José Bines, Richard D. Gelber, Giuseppe Viale, Christoph Thomssen - Journal of Clinical Oncology 2021 被引用: 359

  8. Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2–Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study

    著者: Edith A. Perez, Carlos H. Barrios, W. Eiermann, Masakazu Toi, Young‐Hyuck Im, PierFranco Conte, Miguel Martín, Tadeusz Pieńkowski, Xavier Pivot, Howard A. Burris, Jennifer Petersen, S Stanzel, Alexander Strasak, Monika Patre, Paul Ellis - Journal of Clinical Oncology 2017 被引用: 413

  9. Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study

    著者: Miguel Martín, Elgene Lim, Mariana Chávez‐MacGregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe José Silva Melo Cruz, R. N. Safin, Sung‐Bae Kim, Christian Schem, Alberto J. Montero, Sarah Khan, Reeti Bandyopadhyay, Heather M. Moore, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, Pablo Perez-Moreno, Joohyuk Sohn, for the acelERA Breast Cancer Study Investigators, G. Aguil, Marcos E. Alfie, Valeria Cáceres, Guillermo Lerzo, Sandra A. Ostoich, F. Boyle, Elgene Lim, Hayes Martin, Catherine Oakman, Felipe Melo Cruz, Fábio Franke, André Mattar, E.H. Silva, Katsuki Arima Tiscoski, Wei Chen, Wěi Li, Zhongsheng Tong, Jing Wang, Shaomeng Wang, X. Wang, Jiong Wu, Xiao‐Yuan Wu, Ju Yang, Q. Zhang, Till‐Oliver Emde, G. Gaffunder, Carsten Hielscher, Michael P. Lux, Christian Schem, Manfred Welslau, Claudia Schumacher, I. Kuchuk, T Peretz, Larisa Ryvo, R. Yerushalmi, Hee Dong Chae, Y.S. Chae, Seock‐Ah Im, Hwa Jung Kim, Jie‐Hyun Kim, S.-B. Kim, Jung Eun Lee, Y. H. Park, Joohyuk Sohn, Michał Jarząb, Monika Nowaczyk, Zbigniew Nowecki, Tadeusz Pieńkowski, Marek Z. Wojtukiewicz, Piotr J. Wysocki, E. Fomin, I. P. Ganshina, Nikolay Kislov, М. В. Копп, Н. В. Коваленко, Y. Makarova, Marina Matrosova, Р. В. Орлова, Artem Poltoratsky, Р. Р. Сафин, Р. А. Зуков, A. Wong, Yoon Sim Yap, M.A. Coccia-Portugal, Nicolaas H. Fourie, R. Khanyile, L. Schoeman, Ta‐Chung Chao, S.-T. Chen, Wei‐Pang Chung, Yin‐Hsun Feng, Yung‐Chang Lin, Thitiya Dejthevaporn, Napa Parinyanitikul, Chirawadee Sathitruangsak, Areewan Somwangprasert, Piyawan Tienchaianada, Ahmet Alacacıoğlu ほか 31 名 - Journal of Clinical Oncology 2024 被引用: 63

  10. Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2–positive advanced breast cancer: Final results from MARIANNE

    著者: Edith A. Perez, Carlos H. Barrios, W. Eiermann, Masakazu Toi, Young‐Hyuck Im, PierFranco Conte, Miguel Martín, Tadeusz Pieńkowski, Xavier Pivot, Howard A. Burris, Jennifer Petersen, Sanne de Haas, Silke Hoersch, Monika Patre, Paul Anthony Ellis - Cancer 2019 被引用: 114

  11. A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

    著者: David Cameron, Michelle Casey, Michael F. Press, Deborah Lindquist, Tadeusz Pieńkowski, C. Gilles Romieu, Stephen Chan, Agnieszka Jagiełło-Gruszfeld, Bella Kaufman, John Crown, Arlene Chan, Mario Campone, Patrice Viens, Neville Davidson, Vera Gorbounova, Johannes Isaac Raats, Dimosthenis Skarlos, B. Newstat, Debasish Roychowdhury, Paolo Paoletti, Cristina Oliva, Stephen C. Rubin, Steven Stein, Charles E. Geyer - Breast Cancer Research and Treatment 2008 被引用: 803

  12. Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial

    著者: David Cameron, Julia Brown, Rebecca Dent, Christian Jackisch, John R. Mackey, Xavier Pivot, Guenther G. Steger, Thomas Suter, Masakazu Toi, Mahesh Parmar, R. Laeufle, Young‐Hyuck Im, Gilles Romieu, Vernon Harvey, Oleg Lipatov, Tadeusz Pieńkowski, Paul Cottu, Arlene Chan, Seock‐Ah Im, Peter S Hall, Lida Bubuteishvili‐Pacaud, Volkmar Henschel, Regula Deurloo, Céline Pallaud, Richard H. Bell - The Lancet Oncology 2013 被引用: 436

  13. Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial

    著者: Giampaolo Bianchini, Lajos Pusztai, Tadeusz Pieńkowski, Young‐Hyuck Im, Giulia Bianchi, Ling‐Ming Tseng, M.-C. Liu, Aňa Lluch, Eugenia Galeota, Domenico Magazzù, Juan de la Haba-Rodríguez, Do‐Youn Oh, Brigitte Poirier, José Luiz Pedrini, Semiglazov Vf, Pinuccia Valagussa, Luca Gianni - Annals of Oncology 2015 被引用: 134

  14. Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer

    著者: Giampaolo Bianchini, Astrid Kiermaier, Giulia Bianchi, Young‐Hyuck Im, Tadeusz Pieńkowski, Mei-Ching Liu, Ling‐Ming Tseng, Mitch Dowsett, Lila Zabaglo, S Kirk, Tania Szado, Jennifer Eng‐Wong, Lukas C. Amler, Pinuccia Valagussa, Luca Gianni - Breast Cancer Research 2017 被引用: 129

  15. Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer

    著者: Edith A. Perez, Sanne Lysbet de Haas, W. Eiermann, Carlos H. Barrios, Masakazu Toi, Young-Hyuck Im, PierFranco Conte, Miguel Martín, Tadeusz Pieńkowski, Xavier Pivot, Howard A. Burris, S Stanzel, Monika Patre, Paul Anthony Ellis - BMC Cancer 2019 被引用: 67

  16. Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I–III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial

    著者: Gustavo Ismael, Roberto Hegg, Susanne Muehlbauer, Dominik Heinzmann, Bert Lum, Sung‐Bae Kim, Tadeusz Pieńkowski, Mikhail Lichinitser, Semiglazov Vf, Bohuslav Melichar, Christian Jackisch - The Lancet Oncology 2012 被引用: 346

  17. Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study

    著者: Brian Leyland‐Jones, Semiglazov Vf, Marek Pawlicki, Tadeusz Pieńkowski, Sergei Tjulandin, George Manikhas, Antoly Makhson, Anton Roth, David Dodwell, José Baselga, M. Biakhov, Konstantinas Povilas Valuckas, Э К Возный, Xiangyang Liu, Els Vercammen - Journal of Clinical Oncology 2005 被引用: 665

  18. Multicenter Phase III Randomized Trial Comparing Docetaxel and Trastuzumab With Docetaxel, Carboplatin, and Trastuzumab As First-Line Chemotherapy for Patients With HER2-Gene-Amplified Metastatic Breast Cancer (BCIRG 007 Study): Two Highly Active Therapeutic Regimens

    著者: Vicente Valero, John Forbes, Mark D. Pegram, Tadeusz Pieńkowski, W. Eiermann, Gϋnter von Minckwitz, Henri Roché, Miguel Martín, John Crown, John R. Mackey, P. Fumoleau, Janusz Rolski, Zrinka Mršić-Krmpotić, Agnieszka Jagiełło-Gruszfeld, A. Riva, Marc Buyse, Henry Taupin, Guido Sauter, Michael F. Press, Dennis J. Slamon - Journal of Clinical Oncology 2010 被引用: 259

  19. Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy

    著者: Michael F. Press, Guido Sauter, Marc Buyse, Leslie Bernstein, Roberta Guzman, Angela Santiago, Ivonne Villalobos, W. Eiermann, Tadeusz Pieńkowski, Miguel Martín, Nicholas J. Robert, John Crown, Valerie Bée, Henry Taupin, Kerry Flom, Isabelle Tabah-Fisch, Giovanni M. Pauletti, Mark A. Lindsay, A. Riva, Dennis J. Slamon - Journal of Clinical Oncology 2010 被引用: 220

  20. Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

    著者: Manuela Rabaglio, Zijie Sun, Karen N. Price, Monica Castiglione‐Gertsch, Hanne Hawle, Beat Thürlimann, Henning T. Mouridsen, Mario Campone, JF Forbes, Robert Paridaens, Marco Colleoni, Tadeusz Pieńkowski, Jean‐Marie Nogaret, István Láng, Ian Smith, Richard D. Gelber, Aron Goldhirsch, Alan S. Coates - Annals of Oncology 2009 被引用: 185

  21. Delays in diagnosis and treatment of breast cancer: a multinational analysis

    著者: Jacek Jassem, Vahit Özmen, Florin Bacanu, Monika Drobnienė, J. Eglītis, K C Lakshmaiah, Zsuzsanna Kahán, Jozef Mardiak, Tadeusz Pieńkowski, Т. Yu. Semiglazova, Ljiljana Stamatović, Constanta Timcheva, S. Vasović, Damir Vrbanec, Piotr Zaborek - European Journal of Public Health 2013 被引用: 148

  22. Analysis of Fcγ Receptor IIIa and IIa Polymorphisms: Lack of Correlation with Outcome in Trastuzumab-Treated Breast Cancer Patients

    著者: Sara A. Hurvitz, David J. Betting, Howard M. Stern, Emmanuel Quinaux, Jeremy Stinson, Somasekar Seshagiri, Ying Zhao, Marc Buyse, John R. Mackey, Adrian Driga, Sambasivarao Damaraju, Mark X. Sliwkowski, Nicholas J. Robert, Vicente Valero, John Crown, Carla I. Falkson, Adam Brufsky, Tadeusz Pieńkowski, W. Eiermann, Miguel Martín, Valerie Bée, Omkar Marathe, Dennis J. Slamon, John M. Timmerman - Clinical Cancer Research 2012 被引用: 111

  23. Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update

    著者: Sibylle Loibl, Jacek Jassem, Amir Sonnenblick, Damien Parlier, Eric P. Winer, Jonas Bergh, Richard D. Gelber, Eleonora Restuccia, Young‐Hyuck Im, Chiun‐Sheng Huang, Florence Dalenc, Isabel Calvo, Marion Procter, Carmela Caballero, Emma Clark, Alice Raimbault, Robin McConnell, Estefanía Monturus, Evandro de Azambuja, Henry L. Gómez, Judith M. Bliss, Giuseppe Viale, José Bines, Martine Piccart, Stefan Aebi, Michael Andersson, Jonas Bergh, José Bines, Judith M. Bliss, Hervé Bonnefoi, Carmela Caballero, David Cameron, Fátima Cardoso, Emma Clark, Evandro de Azambuja, Sanne de Haas, Susan Dent, Luis Fein, Elizabeth S. Frank, Richard D. Gelber, Michael Gnant, Henry Gómez, Seock‐Ah Im, Christian Jackisch, Wolfgang Janni, Jacek Jassem, Ian E. Krop, Sherko Kümmel, Tsang‐Wu Liu, Sherene Loi, Sibylle Loibl, Norikazu Masuda, Einav Nili Gam-Yal, Beatrice Nyawira, Tomás Pascual, Martine Piccart, Tadeusz Pieńkowski, Marion Procter, Eleonora Restuccia, Álvaro Rodríguez-Lescure, Thomas Suter, Christoph Thomssen, Vivianne C. G. Tjan‐Heijnen, Gianluca Tomasello, Manuel Roberto Torres Ulloa, Chris Twelves, Giuseppe Viale, Janice M. Walshe, Nicholas Wilcken, Eric P. Winer - Journal of Clinical Oncology 2024 被引用: 30

  24. Au@Pt Core-Shell Nanoparticle Bioconjugates for the Therapy of HER2+ Breast Cancer and Hepatocellular Carcinoma. Model Studies on the Applicability of 193mPt and 195mPt Radionuclides in Auger Electron Therapy

    著者: Kamil Wawrowicz, Agnieszka Majkowska‐Pilip, Damian Gaweł, Ewelina Chajduk, Tadeusz Pieńkowski, Aleksander Bilewicz - Molecules 2021 被引用: 30